Table 3.

Accuracy of self-assessment compared to provider screening for contraindications to progestin-only pills(POPs) in the Self-Screening Study

Provider screening
	Contraindicated to POPs n (%, 95% C.I.)		No contraindications n (%, 95% C.I.)		Total n (%, 95% C.I.)
Self-assessment
Contraindicated to POPs	15	(1.2, 0.7–1.9)	7	(0.6, 0.3–1.1)	22	(1.7, 1.2–2.6)
No contraindications	5	(0.4, 0.2–0.9)	1,240	(97.9, 96.9–98.5)	1,245	(98.3, 97.4–98.9)
Total	20	(1.6, 1.0–2.4)	1,247	(98.4, 97.6–99.0)	1,267	(100.0)

C.I. = Confidence Interval